29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Software Company Fired Employee for Perceived Disability, Federal Agency Charged - RALEIGH, N.C. -...
Read More >
Employers found to have misclassified employees as independent contractors will no longer face the p...
Read More >
Commonly included but rarely invoked, the standard force majeure clause has taken on a life of its o...
Read More >
Please join us for BakerHostetler's “Labor Relations and Employment: The Only Constant Is Change” ...
Read More >
As we previously reported, the Massachusetts Department of Family and Medical Leave (“DFML”) has b...
Read More >
The National Labor Relations Board (the “Board”) recently issued a decision in UPMC Presbyterian S...
Read More >